Lab-in-the-Loop at Compute Speed — Ian Quigley, Leash Bio

Latent Space · 2026-10-14

Lab-in-the-Loop at Compute Speed — Ian Quigley, Leash BioLatent Space ▶ Play the video

Why it earned a slot

Ian Quigley’s walk-through of Leash Bio’s lab-in-the-loop platform demonstrates that compute-speed cycles can now outpace the traditional wet-lab turnaround, turning hypothesis testing into a near-real-time game. The claim that an author’s identity can predict molecular efficacy is provocative, and it forces us to confront data provenance as a first-order feature rather than a footnote. This episode forces a rethink of how we structure discovery pipelines when the bottleneck is no longer compute.

The short version

Your next breakthrough might be hidden in the paper trail.

Why it matters

Protein-ligand binding remains a grand challenge, and the gap between in-silico predictions and wet-lab validation is widening. Leash Bio’s approach shows that integrating author metadata can shortcut that gap, turning historical context into predictive power. For teams building closed-loop R&D pipelines, the cost of a delayed assay now dwarfs the cost of a mis-ranked candidate.

My take

I build agentic AI systems and the lab-in-the-loop model is the closest we have to a true autonomous scientist. Speeding up the compute loop is only half the story; the data you feed the loop—who wrote the assay, what lab conditions were used—must be curated with the same rigor as the model itself. The author-signal insight suggests we’ve been ignoring cheap, high-signal metadata that can dramatically improve ranking. The next frontier is a unified provenance layer that feeds both model and lab.

How it connects

• Metadata-driven ranking → higher hit rates
• Real-time compute loops → reduced time-to-experiment
• Provenance pipelines → better reproducibility

Bottom line

Add author and provenance tags to your molecular datasets and let the model surface their predictive value.